Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

  • Home
  • News
  • Apple Watch Series 9 and Ultra 2 Models in the U.S. to be Sold Without Blood Oxygen App
Image

Apple Watch Series 9 and Ultra 2 Models in the U.S. to be Sold Without Blood Oxygen App

Hey there! Just heard some interesting news about Apple Watch series 9 and Ultra 2 models. It seems that there might be a slight change coming to these watches, as Apple may be removing the Blood Oxygen app from them in the U.S. This move is likely a response to a patent dispute with medical technology company Masimo. The U.S. International Trade Commission had previously ordered an import and sales ban on Apple Watch models with blood oxygen sensing, citing a violation of Masimo’s patents. However, Apple has found a way to temporarily sidestep this ban by removing the app from the new models. Curious to find out more details? Let’s dive in!

Apple Watch Series 9 and Ultra 2 Models in the U.S. to be Sold Without Blood Oxygen App

Apple Watch Series 9 and Ultra 2 Models in the U.S. to be Sold Without Blood Oxygen App

Overview of the Apple Watch Series 9 and Ultra 2 models

The Apple Watch Series 9 and Ultra 2 are the latest models in Apple’s popular smartwatch lineup. These models boast a range of exciting features and improvements over their predecessors, including enhanced performance, improved battery life, and advanced health and fitness tracking capabilities. However, it has recently come to light that these models will be sold in the U.S. without the Blood Oxygen app.

See also  Kroger begins accepting Apple Pay at select stores in Kentucky and Ohio

Removal of the Blood Oxygen app in the U.S. models

The news of the removal of the Blood Oxygen app from the Apple Watch Series 9 and Ultra 2 models sold in the U.S. is a significant development. The app, which measures and displays your body’s blood oxygen percentage, has been a notable feature in previous Apple Watch models. Its absence in the new Series 9 and Ultra 2 models raises questions about the implications for users and their ability to monitor their health.

Apple Watch Series 9 and Ultra 2 Models in the U.S. to be Sold Without Blood Oxygen App

Reasons for the removal of the Blood Oxygen app

The removal of the Blood Oxygen app from the U.S. models can be attributed to an ongoing legal dispute between Apple and medical technology company Masimo. Apple was found to have violated Masimo’s pulse oximetry patents, leading to an import and sales ban on Apple Watch models with blood oxygen sensing. In an effort to comply with the ban and avoid further legal complications, Apple has decided to remove the app from the Series 9 and Ultra 2 models sold in the U.S.

Apple’s response to the import and sales ban

In response to the import and sales ban imposed on Apple Watch models with blood oxygen sensing, Apple has taken steps to modify the affected models. The modified Apple Watch models that do not contain pulse oximetry functionality have been shipped to retail stores in the U.S. However, it is unclear when these modified models will go on sale, as Apple has yet to comment on the matter.

Apple Watch Series 9 and Ultra 2 Models in the U.S. to be Sold Without Blood Oxygen App

Shipping of modified Apple Watch models to retail stores

According to reports, Apple has already initiated the shipping of modified Apple Watch models to retail stores in the U.S. This move indicates Apple’s efforts to comply with the import and sales ban by removing the pulse oximetry functionality from the affected models. The modified models are expected to replace the original Series 9 and Ultra 2 models in the U.S. market.

See also  How to Easily Type Apple's Logo on Mac, iPhone, and iPad

Uncertainty regarding the availability of the modified models

While it has been confirmed that the modified Apple Watch models have been shipped to retail stores, it remains uncertain when these models will be available for purchase. Apple has not provided any specific information or timeline regarding the availability of the modified models. It is advisable for interested customers to stay updated through official announcements and channels to ensure they are aware of any developments.

Apple Watch Series 9 and Ultra 2 Models in the U.S. to be Sold Without Blood Oxygen App

Advertisement of the Blood Oxygen app on Apple’s website

Interestingly, despite the removal of the Blood Oxygen app from the Apple Watch Series 9 and Ultra 2 models sold in the U.S., the app is still being advertised on Apple’s website. As of now, the feature is being promoted as an available feature on the Series 9 and Ultra 2 order pages. However, it is important to note that this may change in the future, as Apple adjusts its marketing strategies in response to the removal of the app from the U.S. models.

Impact on existing owners of the Series 9 and Ultra 2 models

For those who have already purchased the Apple Watch Series 9 or Ultra 2 models, it is unlikely that they will be affected by the removal of the Blood Oxygen app. Existing owners are expected to retain access to the feature, ensuring that they can continue to monitor their blood oxygen levels for wellness purposes. It is worth noting that this is specific to owners of the Series 9 and Ultra 2 models, as other models and regions may not be impacted.

Apple Watch Series 9 and Ultra 2 Models in the U.S. to be Sold Without Blood Oxygen App

Possible software update to adjust the Blood Oxygen app’s algorithms

In an attempt to address the issue caused by the removal of the Blood Oxygen app, Apple is reportedly working on a software update. This update is expected to adjust the app’s algorithms to avoid infringing on Masimo’s patented technology. While the success of this endeavor remains uncertain, it shows Apple’s commitment to resolving the matter and providing a comprehensive solution for users.

See also  Apple's WWDC 2023 Highlights: New Products, Updates, and More

The ongoing legal battle between Apple and Masimo

The removal of the Blood Oxygen app from the U.S. models is a result of an ongoing legal battle between Apple and Masimo. Masimo, a medical technology company, accused Apple of violating its pulse oximetry patents. The import and sales ban imposed on Apple Watch models with blood oxygen sensing was a consequence of this legal dispute. The removal of the app is a temporary measure taken by Apple while the legal battle continues to unfold, highlighting the complexities of patent disputes in the technology industry.

In conclusion, the removal of the Blood Oxygen app from the Apple Watch Series 9 and Ultra 2 models sold in the U.S. is a significant development with implications for users and the ongoing legal battle between Apple and Masimo. While the modified models have been shipped to retail stores, their availability for purchase remains uncertain. Apple’s response, including the potential software update to adjust the app’s algorithms, reflects their dedication to resolving the matter and ensuring a positive user experience. As the legal battle continues, it is important for interested individuals to stay informed through official announcements and channels for the latest updates on this matter.